Literature DB >> 23126553

Engineered nanomaterial risk. Lessons learnt from completed nanotoxicology studies: potential solutions to current and future challenges.

Helinor Johnston1, Giulio Pojana, Stefano Zuin, Nicklas Raun Jacobsen, Peter Møller, Steffen Loft, Manuela Semmler-Behnke, Catherine McGuiness, Dominique Balharry, Antonio Marcomini, Håkan Wallin, Wolfgang Kreyling, Ken Donaldson, Lang Tran, Vicki Stone.   

Abstract

PARTICLE_RISK was one of the first multidisciplinary projects funded by the European Commission's Framework Programme that was responsible for evaluating the implications of nanomaterial (NM) exposure on human health. This project was the basis for this review which identifies the challenges that exist within the assessment of NM risk. We have retrospectively reflected on the findings of completed nanotoxicology studies to consider what progress and advances have been made within the risk assessment of NMs, as well as discussing the direction that nanotoxicology research is taking and identifying the limitations and failings of existing research. We have reflected on what commonly encountered challenges exist and explored how these issues may be resolved. In particular, the following is discussed (i) NM selection (ii) NM physico-chemical characterisation; (iii) NM dispersion; (iv) selection of relevant doses and concentrations; (v) identification of relevant models, target sites and endpoints; (vi) development of alternatives to animal testing; and (vii) NM risk assessment. These knowledge gaps are relatively well recognised by the scientific community and recommendations as to how they may be overcome in the future are provided. It is hoped that this will help develop better defined hypothesis driven research in the future that will enable comprehensive risk assessments to be conducted for NMs. Importantly, the nanotoxicology community has responded and adapted to advances in knowledge over recent years to improve the approaches used to assess NM hazard, exposure and risk. It is vital to learn from existing information provided by ongoing or completed studies to avoid unnecessary duplication of effort, and to offer guidance on aspects of the experimental design that should be carefully considered prior to the start of a new study.

Entities:  

Mesh:

Year:  2012        PMID: 23126553     DOI: 10.3109/10408444.2012.738187

Source DB:  PubMed          Journal:  Crit Rev Toxicol        ISSN: 1040-8444            Impact factor:   5.635


  26 in total

1.  Probabilistic risk assessment of gold nanoparticles after intravenous administration by integrating in vitro and in vivo toxicity with physiologically based pharmacokinetic modeling.

Authors:  Yi-Hsien Cheng; Jim E Riviere; Nancy A Monteiro-Riviere; Zhoumeng Lin
Journal:  Nanotoxicology       Date:  2018-04-14       Impact factor: 5.913

2.  Assessing the acute hazards of zinc oxide nanomaterials to Lumbriculus variegatus.

Authors:  Shona O'Rourke; Vicki Stone; Björn Stolpe; Teresa F Fernandes
Journal:  Ecotoxicology       Date:  2015-07-15       Impact factor: 2.823

Review 3.  Evaluating the mechanistic evidence and key data gaps in assessing the potential carcinogenicity of carbon nanotubes and nanofibers in humans.

Authors:  Eileen D Kuempel; Marie-Claude Jaurand; Peter Møller; Yasuo Morimoto; Norihiro Kobayashi; Kent E Pinkerton; Linda M Sargent; Roel C H Vermeulen; Bice Fubini; Agnes B Kane
Journal:  Crit Rev Toxicol       Date:  2016-08-18       Impact factor: 5.635

4.  Ethical issues in nanomedicine: Tempest in a teapot?

Authors:  Irit Allon; Ahmi Ben-Yehudah; Raz Dekel; Jan-Helge Solbakk; Klaus-Michael Weltring; Gil Siegal
Journal:  Med Health Care Philos       Date:  2017-03

5.  Quantitative assessment of inhalation exposure and deposited dose of aerosol from nanotechnology-based consumer sprays.

Authors:  Yevgen Nazarenko; Paul J Lioy; Gediminas Mainelis
Journal:  Environ Sci Nano       Date:  2014-04

6.  Biological Influence of Pulmonary Disease Conditions Induced by Particulate Matter on Microfluidic Lung Chips.

Authors:  Faiza Jabbar; Young-Su Kim; Sang Ho Lee
Journal:  Biochip J       Date:  2022-07-08       Impact factor: 4.229

7.  A methodology for developing key events to advance nanomaterial-relevant adverse outcome pathways to inform risk assessment.

Authors:  Sabina Halappanavar; James D Ede; Indrani Mahapatra; Harald F Krug; Eileen D Kuempel; Iseult Lynch; Rob J Vandebriel; Jo Anne Shatkin
Journal:  Nanotoxicology       Date:  2020-12-14       Impact factor: 5.913

8.  A Complete In Vitro Toxicological Assessment of the Biological Effects of Cerium Oxide Nanoparticles: From Acute Toxicity to Multi-Dose Subchronic Cytotoxicity Study.

Authors:  Adrián García-Salvador; Alberto Katsumiti; Elena Rojas; Carol Aristimuño; Mónica Betanzos; Marta Martínez-Moro; Sergio E Moya; Felipe Goñi-de-Cerio
Journal:  Nanomaterials (Basel)       Date:  2021-06-16       Impact factor: 5.076

Review 9.  Interactions between nanosized materials and the brain.

Authors:  M Simkó; Mats-Olof Mattsson
Journal:  Curr Med Chem       Date:  2014       Impact factor: 4.530

10.  Environmental impact of multi-wall carbon nanotubes in a novel model of exposure: systemic distribution, macrophage accumulation, and amyloid deposition.

Authors:  Adriana Albini; Arianna Pagani; Laura Pulze; Antonino Bruno; Elisa Principi; Terenzio Congiu; Elisabetta Gini; Annalisa Grimaldi; Barbara Bassani; Silvio De Flora; Magda de Eguileor; Douglas M Noonan
Journal:  Int J Nanomedicine       Date:  2015-09-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.